Ami Organics Ltd - 543349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication for the Corrigendum to Postal Ballot Notice dated April 26, 2024 is herewith enclosed.13-05-2024
13-05-2024
Ami Organics Ltd - 543349 - Recording Of The Earnings Call Held On May 13, 2024
Recording of the Earnings Call held on May 13, 2024 as attached.13-05-2024
Q4FY24 Quarterly Result Announced for Ami Organics Ltd.
Pharmaceuticals company Ami Organics announced Q4FY24 & FY24 results: Revenue from operations for Q4FY24 grew by 20.7% YoY and 35.2% QoQ to Rs 2,250 million The gross margin for the quarter was at 40.0%. Gross margins were impacted due to change in product mix. EBITDA for the quarter came at Rs 432 million up 5.9% YoY compared to Rs 408 million in Q4FY23 and up 62.8% QoQ compared to Rs 265 million in Q3FY24. EBITDA margin for the quarter was at 19.2% as compared to 21.9% in Q4FY23 and 15.9% in Q3FY24. EBITDA margins contracted by 269bps YoY and grew by 326 bps sequentially. Adjusted PAT for the quarter was Rs 260 million. Adjusted PAT margin for the quarter was 11.6%. Commenting on results, Naresh Patel, Executive Chairman & Managing Director, Ami Organics, said: “I am pleased to share that we have been successful in navigating through the tough industry scenario to deliver an all-time high quarterly revenue from operations of Rs 225 crore. This represents a growth of 21% YoY and an exceptional 35% sequential growth. Our advanced pharmaceuticals business, grew strongly by 18% YoY and 47% QoQ while our specialty chemicals business grew robustly by 36% YoY during the quarter. I am delighted to share that we have achieved the 'Gold Medal' accreditation from EcoVadis. Although we are in chemicals manufacturing industry, we remain steadfast on our sustainability goals propelled by an intensified focus on green chemistry and green initiatives. This commitment underscores our proactive approach to environmental responsibility and sustainability. I am also thrilled to inform you that recently we have received grant of 3 process patents from The Patent Office, Government of India. Two of these three products are niche and complex in nature. Overall, I believe that we have navigated industry challenges adeptly in FY24 and as we progress ahead with improved overall prospects for the industry, we firmly believe we will sustain our growth trajectory, targeting a revenue growth in range of 20-25% for the fiscal year FY25.” Result PDF13-05-2024
Ami Organics Ltd - 543349 - Statement Of Deviation & Variation For The Quarter Ended March 31, 2024.
Statement of Deviation & Variation for the quarter ended March 31, 2024 is herewith attached.11-05-2024
Ami Organics Ltd - 543349 - Compliances-Reg.24(A)-Annual Secretarial Compliance
The Annual Secretarial Compliance Report for the financial year ended March 31, 2024 is herewith enclosed.11-05-2024
Ami Organics Ltd - 543349 - Corrigendum To The Postal Ballot Notice Dated April 26, 2024
Corrigendum to the Postal Ballot Notice dated April 26, 2024 being issued today to inform the shareholders with respect to amendment in Explanatory Statement of the Postal Ballot Notice is herewith attached.11-05-2024
Ami Organics Ltd - 543349 - Corporate Action-Board approves Dividend
Board has approved a final dividend of Rs. 3/- per Equity Shares on 3,68,80,562 number of Equity Shares of the Company for the FY 2023-24 subject to the confirmation by shareholders in the ensuing Annual General Meeting of the Company as per details attached.11-05-2024
Ami Organics Ltd - 543349 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on fourth quarter and year ended financial results as on March 31, 2024 is attached11-05-2024
Ami Organics Ltd - 543349 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release discussing the fourth quarter and year ended financial results as on March 31, 2024 is attached11-05-2024
Ami Organics Ltd - 543349 - Related Party Transactions For The Half Year Ended March 31, 2024
Related Party Transactions for the half year ended March 31, 2024 is enclosed.10-05-2024